Best Zongertinib (Hernexeos) Medicine in India

Zongertinib (Hernexeos) is a targeted anticancer treatment used to treat adults with unresectable or metastatic non-squamous non-small cell lung cancer (NSCLC) whose tumors have specific HER2 (ERBB2) tyrosine kinase domain mutations. It belongs to a group of medicines called kinase inhibitors and works by blocking abnormal HER2 signaling that promotes cancer-cell growth and survival, helping to slow the progression of the disease.

Zongertinib (Hernexeos) should be taken exactly as prescribed by your doctor. It can be taken with or without food, and should be taken at approximately the same time each day. Swallow it whole with water and do not crush, chew, or break it. Regular medical check-ups and laboratory tests may be required to monitor your response to treatment and detect possible side effects.

Common side effects of Zongertinib (Hernexeos) may include diarrhea, rash, muscle or joint pain, nail changes, fatigue, nausea, decreased appetite, and increased liver enzymes. It may also cause serious lung, liver, or heart-related problems in some patients. Inform your doctor if you develop new or worsening cough, breathing difficulties, significant swelling, unusual tiredness, or other concerning symptoms. Before starting treatment, tell your doctor about your medical history and all medicines, vitamins, and supplements you are taking.

Treatment of HER2-Mutated Non-Small Cell Lung Cancer

Zongertinib (Hernexeos) is used to treat adults with unresectable or metastatic non-squamous non-small cell lung cancer (NSCLC) with specific HER2 (ERBB2) tyrosine kinase domain mutations. It blocks abnormal HER2 signaling in cancer cells, helping to slow tumor growth and disease progression.

Some side effects of Zongertinib (Hernexeos) may improve as the body adjusts to the treatment. Consult your doctor if any side effect persists, becomes severe, or causes concern.

Common Side Effects of Zongertinib (Hernexeos)

Take Zongertinib (Hernexeos) exactly as prescribed by your doctor. It can be taken with or without food and should be taken at approximately the same time each day. Swallow it whole with water and do not crush, chew, or break it. Follow your doctor's instructions if you miss a dose or vomit after taking it. Continue treatment as recommended and attend regular medical check-ups and laboratory tests.

Zongertinib (Hernexeos) is a HER2 tyrosine kinase inhibitor that targets specific activating HER2 (ERBB2) mutations in cancer cells. It blocks abnormal HER2 signaling involved in cancer-cell growth and survival, helping to inhibit tumor growth and slow disease progression.

• Store Hernexeos tablets at room temperature between 20°C and 25°C; excursions from 15°C to 30°C are permitted.
• Keep the tablets in the original bottle to protect them from moisture.
• Keep the bottle tightly closed and do not remove the desiccants.
• After first opening, use the tablets within 3 months and discard any unused tablets afterward.

Alcohol CONSULT YOUR DOCTOR

Limit alcohol during treatment, as it may worsen side effects such as nausea, fatigue, or dizziness. Follow your doctor's advice.

Pregnancy CONSULT YOUR DOCTOR

Zongertinib may harm an unborn baby. Women who can become pregnant should use effective contraception during treatment and for the recommended period after the last dose.

Breastfeeding CONSULT YOUR DOCTOR

Do not breastfeed during treatment and for the recommended period after the last dose, as the drug may pass into breast milk.

Driving CONSULT YOUR DOCTOR

Avoid driving or operating machinery if you experience fatigue, dizziness, or other effects that may affect your alertness.

Kidney CAUTION

Inform your doctor if you have kidney problems. Your doctor may monitor kidney function during treatment and provide appropriate medical care.

Liver CAUTION

Tell your doctor about any liver condition. Regular liver function tests may be performed, and report yellowing of the skin or eyes, dark urine, or unusual tiredness promptly.

• Take Zongertinib (Hernexeos) exactly as prescribed and at approximately the same time each day.
• Report new or worsening cough, breathing difficulties, or chest discomfort promptly.
• Tell your doctor if you develop severe diarrhea, rash, swelling, or unusual tiredness.
• Attend regular blood tests and medical check-ups to monitor liver function and other treatment-related effects.
• Inform your doctor about all medicines, vitamins, and supplements you are taking before starting treatment.
• Read More About - Zongertinib (Hernexeos) from Pharma Five.

Pharma Five, can facilitate patients in importing Zongertinib (Hernexeos) in small quantities for personal use. For this purpose, the applicant is required to submit an application in Form 12A along with a prescription issued by a Registered Medical Practitioner (RMP).

Pharma Five offers professional pharmaceutical facilitation services to support patients seeking access to Zongertinib (Hernexeos) and other specialized pharmaceutical products through appropriate import procedures. Pharma Five provides extensive pharmaceutical service coverage across India, serving patients and healthcare requirements in prominent cities such as Mumbai, Delhi, Kolkata, Bhubaneswar, Bangalore, Hyderabad, Chennai, Ahmedbad, Pune, Surat, Visakhapatnam, Jaipur, Lucknow, Nagpur, Indore, Patna, Agartala, Guwahati, Imphal, Kohima, Namchi, Noida, Ghaziabad, Ludhiana, Agra, Varanasi, Srinagar, Amritsar, Jodhpur, Chandigarh, Gurgaon, Gorakhpur, Dehradun, Jammu, Hyderabad, Thiruvananthapuram, Kochi, Coimbatore, Puducherry, Mysuru, Salem, Vellore, Tiruppur, Guntur, Goa, Kolhapur, Mumbai, Nashik, and various other regions in India.